COMMUNIQUÉS West-GlobeNewswire

Pediapharm annonce des acquisitions transformatrices et un placement de 60 millions de dollars de reçus de souscription
12/09/2018
NON DESTINÉ À LA DISTRIBUTION AUX AGENCES DE PRESSE AMÉRICAINES NI À LA DIFFUSION AUX ÉTATS-UNIS LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION AMÉRICAINE SUR LES VALEURS MOBILIÈRES [...]
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid Epidemic
12/09/2018
MIAMI, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in [...]
Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial
12/09/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system
12/09/2018
CARDIFF, United Kingdom, Sept. 12, 2018 (GLOBE NEWSWIRE) -- TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged to build a custom- [...]
XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board
12/09/2018
AUSTIN, Texas, Sept. 12, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) is pleased to announce the appointment of Peter Libby, MD to its Scientific Advisory Board (SAB). Dr. Libby will work with XBiotech to help [...]
Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership
12/09/2018
Partnership Involves Commercial-scale Production of hRS7, the Antibody Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and INCHEON, South Korea, Sept. 12, 2018 (GLOBE [...]
Athenex and its Collaborative Partner, Hanmi Pharmaceutical, Announce Strategic Realignment of their Joint Projects
12/09/2018
BUFFALO, N.Y., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Emblem signs supply agreement with Aphria to purchase up to 175,000 kg equivalents of cannabis products over five years
12/09/2018
TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]
Actor Jeremy Miller Appears on Local ABC News Supporting BioCorRx Recovery Program
12/09/2018
ANAHEIM, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today [...]
MRI Interventions to Present at Sidoti & Co. 2018 Fall Conference on Sept 27
12/09/2018
LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall Conference on Thursday, [...]
Apellis Pharmaceuticals Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophy
12/09/2018
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T
12/09/2018
RICHMOND HILL, Ontario, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP), (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Trillium Therapeutics Announces Data Presentations at Upcoming Scientific Meetings
12/09/2018
Updated safety and efficacy data from the TTI-621 intravenous trial at the 16th Annual Discovery on Target Conference Updated data from the TTI-621 intralesional trial in patients with mycosis fungoides and Sézary [...]
RedHill Biopharma Announces Positive End-of-Phase II Meeting with FDA on BEKINDA® for IBS-D
12/09/2018
The positive Type B meeting with the FDA followed a successful Phase II study of BEKINDA ® for diarrhea-predominant irritable bowel syndrome (IBS-D), one of the most common gastrointestinal disorders In light of the [...]
Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
12/09/2018
FREMONT, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions [...]
Pernix Therapeutics Holdings, Inc.’s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
12/09/2018
MORRISTOWN, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), announced today that, on September 7, 2018, its subsidiaries, Pernix Therapeutics, LLC, a specialty pharmaceutical [...]
Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth
12/09/2018
Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth Research Triangle Park, NC and Cambridge, UK, September 12, 2018 -- Inivata , a leader in liquid biopsy, today announces the strengthening of [...]
Aleafia Completes Second Harvest with Sale to Licensed Producer Imminent
12/09/2018
Clinic Operations and Cannabis Sales Providing Immediate Multiple Income Streams TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), one [...]
Cyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of Directors
12/09/2018
- Former CMO of Schering-Plough Joins Cyclacel Board - BERKELEY HEIGHTS, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a [...]

Pages